Target intelligence / Profile preview

Flotillin-1 (FLOT1)

Target
FLOT1
Molecular classification
Membrane-associated scaffolding protein, SPFH (stomatin, prohibitin, flotillin, HflK/C) superfamily, Lipid raft–associated protein, Other
01

Overview

Flotillin-1 is a membrane-associated protein and member of the SPFH (stomatin, prohibitin, flotillin, HflK/C) superfamily, encoded by the FLOT1 gene on chromosome 6[1][2][4]. It is widely expressed in human tissues and primarily localizes to the cytoplasmic side of the plasma membrane, as well as to certain intracellular compartments including the Golgi, lysosomes, endosomes, and nuclei[1][4]. Flotillin-1 forms hetero-oligomeric complexes with flotillin-2, enhancing membrane raft stabilization and organization[3][4]. As a scaffolding protein, flotillin-1 is central to the formation and functional organization of lipid rafts—specialized membrane microdomains involved in cell signaling, receptor trafficking, and endocytosis (including clathrin-independent pathways)[1][2][4]. It facilitates the endocytosis and membrane cycling of several key transporters and receptors, such as the dopamine transporter, IGF-1 receptor, and muscarinic M3 receptor[1]. Flotillin-1 is also an established marker for exosomes and serves various roles in membrane trafficking and signal transduction[1][4]. Post-translational modifications, such as S-palmitoylation, sumoylation, and phosphorylation, regulate flotillin-1’s membrane association, subcellular localization, and function[1][2][4]. Aberrant flotillin-1 expression or modification is linked to pathological processes, including tumor development (where it can function as either oncogene or tumor suppressor context-dependently), neurodegenerative diseases like Parkinson's disease, infections, cardiovascular pathology, metabolic disorders, and more[1][4]. Although flotillin-1 is not a conventional therapeutic target (such as a receptor, ion channel, enzyme, or transporter), its implications in disease progression and as a biomarker have been increasingly recognized, particularly in oncology and neurological research[1][4]. No direct drugs targeting flotillin-1 are currently established, but its modulation impacts the efficacy or localization of several druggable targets.

Other names
flotillin 1integral membrane component of caveolaeFLOT1flotillin-1
02

Biological functions

Signal transductionEndocytosis (particularly clathrin-independent endocytosis)Membrane traffickingCell adhesionOrganization of plasma membrane lipid raftsProtein transportCell proliferationModulation of ion and neurotransmitter transportersRegulation of receptor localization and signaling
03

Disease associations

CancerNeurodegenerative diseaseCardiovascular disease (dilated cardiomyopathy)Infection (pathogenic microbial infection)Metabolic disease (diabetes-related disease)Gynecological diseaseOther
04

Safety considerations

Potential oncogenic signaling roles in cancersAberrant expression linked to abnormal endocytosis in neurological diseaseAltered lipid metabolism (e.g., sphingolipid/S1P regulation)Possible impact on central nervous system functions via neurotransmission and synaptic regulation
05

Biomarkers

Marker of exosomesMembrane raft markerPrognostic marker for certain cancers

Beyond the preview

Go deeper on Flotillin-1 (FLOT1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Flotillin-1 (FLOT1).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call